As Diabetes Crisis Grows, Hyperion Cancels Drug Production Amid Scandal
According to a new report from Chicago Tribune, pharmaceuticals giant Hyperion Therapeutics Inc. has ordered an immediate halt on the production of a new drug for diabetes being developed by one of its subsidiaries. A statement from the company said that Andromeda Biotech Ltd., based out of Israel, has illegally been manipulating the test data […]